Filing Details

Accession Number:
0001104659-12-040042
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-25 13:50:30
Reporting Period:
2012-05-24
Filing Date:
2012-05-25
Accepted Time:
2012-05-25 13:50:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
808722 M David Knott 485 Underhill Blvd
Ste 205
Syosset NY 11791-3419
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-24 172,100 $11.62 972,100 No 4 P Indirect By Knott Partners, L.P.
Common Stock Acquisiton 2012-05-24 23,900 $11.62 264,661 No 4 P Indirect By Shoshone Partners, L.P.
Common Stock Disposition 2012-05-24 98,633 $11.62 0 No 4 S Indirect By Mulsanne Partners, L.P.
Common Stock Disposition 2012-05-24 76,167 $11.62 331,396 No 4 S Indirect By Knott Partners Offshore Master Fund, L.P.
Common Stock Disposition 2012-05-24 21,200 $11.62 41,583 No 4 S Indirect By Managed Account D
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Knott Partners, L.P.
No 4 P Indirect By Shoshone Partners, L.P.
No 4 S Indirect By Mulsanne Partners, L.P.
No 4 S Indirect By Knott Partners Offshore Master Fund, L.P.
No 4 S Indirect By Managed Account D
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,666 Indirect By Managed Account C
Common Stock 54,704 Direct
Footnotes
  1. Each entry reports a component of a cross transaction in the shares set forth in column 1 of Table I among the accounts identified in Column 7 of Table I that are coded P or S in Column 3. The cross transactions reported reflect a reallocation of shares among the partnerships and the Reporting Person's managed clients for which there were no net transaction costs, and the accounts that disposed of shares in the cross transaction did not acquire any shares in the cross transaction.
  2. The Reporting Person is the managing member of Knott Partners Management, LLC, which is (a) the sole general partner of Shoshone Partners, L.P., Knott Partners Offshore Master Fund, L.P. and Mulsanne Partners, L.P. and (b) the managing general partner of Knott Partners, L.P. The Reporting Person is also a general partner of Knott Partners, L.P.
  3. The Reporting Person is the sole director and the president of Dorset Management Corporation, which (a) provides investment management services to Knott Partners Offshore (SRI) Fund Limited and (b) separate institutional managed accounts (each, a "Managed Account").
  4. As a result of the Reporting Person's interests in Knott Partners Management, LLC and in Dorset Management Corporation, the Reporting Person has investment discretion and control of the securities in this entry. The Reporting Person may be deemed to beneficially own an indirect pecuniary interest in securities in this entry as a result of a performance related fee. Except with respect to Knott Partners, L.P., Knott Partners Offshore Master Fund, L.P., Shoshone Partners, L.P., and Mulsanne Partners, L.P., in which the Reporting Person owns a beneficial interest, the Reporting Person disclaims beneficial ownership therein except to the extent ultimately realized. Each of Knott Partners, L.P., Knott Partners Offshore Master Fund, L.P., Shoshone Partners, L.P., Mulsanne Partners, L.P., Knott Partners Offshore (SRI) Fund Limited, and each of the Managed Accounts disclaims beneficial ownership of securities reported as owned by any other party.